These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 15632892)
1. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Schouten O; Poldermans D; Visser L; Kertai MD; Klein J; van Urk H; Simoons ML; van de Ven LL; Vermeulen M; Bax JJ; Lameris TW; Boersma E Am Heart J; 2004 Dec; 148(6):1047-52. PubMed ID: 15632892 [No Abstract] [Full Text] [Related]
2. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D; Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688 [TBL] [Abstract][Full Text] [Related]
3. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213 [TBL] [Abstract][Full Text] [Related]
4. Fluvastatin and perioperative events in patients undergoing vascular surgery. Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D; N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772 [TBL] [Abstract][Full Text] [Related]
6. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery. Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C; Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084 [TBL] [Abstract][Full Text] [Related]
8. Does time of onset of therapy alter the protective cardiovascular effect of fluvastatin after renal transplantation? Morales JM Nat Clin Pract Nephrol; 2005 Dec; 1(2):78-9. PubMed ID: 16932372 [No Abstract] [Full Text] [Related]
9. Reducing cardiac risk in noncardiac surgery. Lee TH N Engl J Med; 1999 Dec; 341(24):1838-40. PubMed ID: 10588971 [No Abstract] [Full Text] [Related]
10. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414 [TBL] [Abstract][Full Text] [Related]
12. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Poldermans D; Boersma E; Bax JJ; Thomson IR; van de Ven LL; Blankensteijn JD; Baars HF; Yo TI; Trocino G; Vigna C; Roelandt JR; van Urk H N Engl J Med; 1999 Dec; 341(24):1789-94. PubMed ID: 10588963 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone. Singer P Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):379-80. PubMed ID: 15850720 [No Abstract] [Full Text] [Related]
14. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study. Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H; Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic beta-blocker use to prevent perioperative morbidity and mortality. Finley AC; Elliott BM; Robison JJ; Brothers TE J S C Med Assoc; 2004 Aug; 100(8):223-6. PubMed ID: 15490951 [TBL] [Abstract][Full Text] [Related]
16. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054 [TBL] [Abstract][Full Text] [Related]
17. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease. Lemos PA; de Feyter PJ; Serruys PW; Saia F; Arampatzis CA; Disco C; Mercado N; Mainar V; Morís C; van den Bos AA; Berghoefer G Int J Cardiol; 2005 Feb; 98(3):479-86. PubMed ID: 15708183 [TBL] [Abstract][Full Text] [Related]